Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats.
7(th) International Immunoglobulin Conference: Interlaken Leadership Awards.
bFGF Protects Pre-oligodendrocytes from Oxygen/Glucose Deprivation Injury to Ameliorate Demyelination.
Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
Pangaea 2.0: State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod.
Long-distance effects of inflammation on differentiation of adult spinal cord neural stem/progenitor cells.
Electropysiologic evaluation of the visual pathway in patients with multiple sclerosis.
Myoinositol trends in different types of brain lesions.
Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.
Social support and depressive symptoms among caregivers of veterans with multiple sclerosis.
Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis.
Requirement of CD30 expression on CD4 T cells in the pathogenesis of experimental autoimmune encephalomyelitis.
"History had taken such a large piece out of my life" - Neuroscientist refugees from Hamburg during National Socialism.
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
Liver Damage and Mortality in a Male Lewis Rat of Experimental Autoimmune Encephalomyelitis.
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.
Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
Microvesicles in the brain: Biomarker, messenger or mediator?
Evidence for the Importance of Vitamin D Status in Neurologic Conditions.
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.

Pages